{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:30:46Z","timestamp":1785198646406,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bbrc.2020.03.102","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T02:30:54Z","timestamp":1585794654000},"page":"568-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gefitinib modulates stress fibers and tubular-like structure formation and attenuates angiogenesis in an in\u00a0vivo chicken model of chorioallantoic membrane angiogenesis"],"prefix":"10.1016","volume":"526","author":[{"given":"Tsung-Chieh","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.03.102_bib1","first-page":"2053","article-title":"Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor","volume":"6","author":"Ciardiello","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib2","first-page":"897","article-title":"Modulation of tumor growth and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 in renal cell carcinoma","volume":"171","author":"Asakuma","year":"2004","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.bbrc.2020.03.102_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biopha.2018.02.110","article-title":"Gefitinib inhibits retina angiogenesis by affecting VEGF signaling pathway","volume":"102","author":"Hu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2020.03.102_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2710.2004.00543.x","article-title":"Gefitinib, a novel, orally administered agent for the treatment of cancer","volume":"29","author":"Ranson","year":"2004","journal-title":"J.\u00a0Clin. Pharm. Therapeut."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2020.03.102_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-200060001-00002","article-title":"Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy","volume":"60","author":"Raymond","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2020.03.102_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0163-7258(98)00045-X","article-title":"The epidermal growth factor receptor and its inhibition in cancer therapy","volume":"82","author":"Woodburn","year":"1999","journal-title":"Pharmacol. Ther."},{"issue":"Suppl 4","key":"10.1016\/j.bbrc.2020.03.102_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.7-suppl_4-31","article-title":"Epidermal growth factor receptor dependence in human tumors: more than just expression?","volume":"7","author":"Arteaga","year":"2002","journal-title":"Oncol."},{"key":"10.1016\/j.bbrc.2020.03.102_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2168.2001.01686.x","article-title":"Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation","volume":"88","author":"Chan","year":"2001","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bbrc.2020.03.102_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(97)00052-1","article-title":"Protein kinase inhibitors: the tyrosine-specific protein kinases","volume":"77","author":"Lawrence","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2020.03.102_bib10","first-page":"4885","article-title":"Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase","volume":"6","author":"Sirotnak","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib11","first-page":"2926","article-title":"Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma","volume":"60","author":"Bruns","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib12","first-page":"1459","article-title":"Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor","volume":"7","author":"Ciardiello","year":"2001","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib13","first-page":"257","article-title":"Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice","volume":"5","author":"Perrotte","year":"1999","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib14","first-page":"2554","article-title":"ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase","volume":"62","author":"Hirata","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1349-7006.2004.tb02496.x","article-title":"Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib (\u2019Iressa\u2019, ZD1839)","volume":"95","author":"Hirata","year":"2004","journal-title":"Canc. Sci."},{"key":"10.1016\/j.bbrc.2020.03.102_bib16","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s10495-006-0192-8","article-title":"Norepinephrine induces apoptosis in neonatal rat endothelial cells via a ROS-dependent JNK activation pathway","volume":"11","author":"Fu","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2020.03.102_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cardiores.2003.10.014","article-title":"Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways","volume":"61","author":"Fu","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4800(86)90002-X","article-title":"Matrix fibronectin disruption in association with altered endothelial cell adhesion induced by activated polymorphonuclear leukocytes","volume":"45","author":"Richards","year":"1986","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2020.03.102_bib19","first-page":"640","article-title":"Single cell analysis of transfected gene expression in primary heart cultures containing multiple cell types","volume":"6","author":"Antin","year":"1988","journal-title":"Biotechniques"},{"key":"10.1016\/j.bbrc.2020.03.102_bib20","first-page":"5237","article-title":"MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2020.03.102_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1158\/1538-7445.AM2020-CT284","article-title":"Long non-coding RNA HOXA11-AS upregulates Cyclin D2 to inhibit apoptosis and promote cell cycle progression in nephroblastoma by recruiting forkhead box P2","volume":"10","author":"Zhu","year":"2020","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41429-018-0066-7","article-title":"Bafilomycin C1 induces G0\/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells","volume":"71","author":"Gao","year":"2018","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbrc.2020.03.102_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/REP-17-0667","article-title":"Sphingolipid synthesis and role in uterine epithelia proliferation","volume":"156","author":"Cerbon","year":"2018","journal-title":"Reproduction"},{"key":"10.1016\/j.bbrc.2020.03.102_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers5010027","article-title":"Integrin alpha5beta1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors","volume":"5","author":"Schaffner","year":"2013","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2020.03.102_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-94-017-9153-3_3","article-title":"alpha2beta1 Integrin","volume":"819","author":"Madamanchi","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2020.03.102_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jb\/mvu053","article-title":"A\u00a0new link between the retrograde actin flow and focal adhesions","volume":"156","author":"Yamashiro","year":"2014","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2020.03.102_bib27","first-page":"2573","article-title":"Inhibition of cell migration by focal adhesion kinase: time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells","volume":"41","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2020.03.102_bib28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3892\/ijo_00000448","article-title":"Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity","volume":"35","author":"Kanda","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2020.03.102_bib29","first-page":"1566","article-title":"Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect","volume":"9","author":"Tortora","year":"2003","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib30","first-page":"4300","article-title":"Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa)","volume":"62","author":"Huang","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.102_bib31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/sj.bjc.6603308","article-title":"Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126","volume":"95","author":"Bozec","year":"2006","journal-title":"Br. J. Canc."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20305933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20305933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:49:54Z","timestamp":1757764194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20305933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0006291X20305933"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.102","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gefitinib modulates stress fibers and tubular-like structure formation and attenuates angiogenesis in an in\u00a0vivo chicken model of chorioallantoic membrane angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}